Last updated on July 2019

Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients


Brief description of study

To characterize the pharmacokinetics (PK) of naloxegol after single oral dose and through population PK in paediatric patients with opioid induced constipation (OIC) or at risk of OIC.

Clinical Study Identifier: NCT02099591

Find a site near you

Start Over

Research Site

Phoenix, AZ United States
  Connect »

Rigshospitalet

Copenhagen, Denmark
  Connect »

Royal Marsden Hospital

London, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.